Tumor burden as the most important prognostic factor in early stage Hodgkin's disease.Relations to other prognostic factors and implications for choice of treatment
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference18 articles.
1. Tumour burden in early stage Hodgkin's disease: the single most important prognostic factor for outcome after radiotherapy
2. The significance of mediastinal involvement in early stage Hodgkin's disease
3. Further follow-up of results of treatment in 90 laparotomy-negative stage I and II Hodgkin's disease patients: Significance of mediastinal and non-mediastinal presentations
Cited by 86 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Baseline metabolic tumour burden improves risk stratification in Hodgkin lymphoma: A Children's Oncology Group study;British Journal of Haematology;2023-03-15
2. Methodological Aspects and the Prognostic Value of Metabolic Tumor Volume assessed with 18F-FDG PET/CT in Lymphomas;Current Radiopharmaceuticals;2022-12
3. Imaging to predict checkpoint inhibitor outcomes in cancer. A systematic review;European Journal of Cancer;2022-11
4. Pre‐treatment total metabolic tumour volumes in lymphoma: Does quantity matter?;British Journal of Haematology;2022-01-17
5. Total tumor burden in lymphoma – an evolving strong prognostic parameter;The British Journal of Radiology;2021-11-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3